Figure 2From: Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysisForest plot for meta-analysis of bone pain of patients treated with zoledronic acid (ZOL) versus no ZOL.Back to article page